Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 46

1.

Joint sequencing of human and pathogen genomes reveals the genetics of pneumococcal meningitis.

Lees JA, Ferwerda B, Kremer PHC, Wheeler NE, Serón MV, Croucher NJ, Gladstone RA, Bootsma HJ, Rots NY, Wijmega-Monsuur AJ, Sanders EAM, Trzciński K, Wyllie AL, Zwinderman AH, van den Berg LH, van Rheenen W, Veldink JH, Harboe ZB, Lundbo LF, de Groot LCPGM, van Schoor NM, van der Velde N, Ängquist LH, Sørensen TIA, Nohr EA, Mentzer AJ, Mills TC, Knight JC, du Plessis M, Nzenze S, Weiser JN, Parkhill J, Madhi S, Benfield T, von Gottberg A, van der Ende A, Brouwer MC, Barrett JC, Bentley SD, van de Beek D.

Nat Commun. 2019 May 15;10(1):2176. doi: 10.1038/s41467-019-09976-3.

2.

Early measles vaccination during an outbreak in The Netherlands: reduced short and long-term antibody responses in children vaccinated before 12 months of age.

Brinkman ID, de Wit J, Smits GP, Ten Hulscher HI, Jongerius MC, Abreu TC, van der Klis FRM, Hahné SJM, Koopmans MPG, Rots NY, van Baarle D, van Binnendijk RS.

J Infect Dis. 2019 Apr 11. pii: jiz159. doi: 10.1093/infdis/jiz159. [Epub ahead of print]

3.

Maternal pertussis vaccination and its effects on the immune response of infants aged up to 12 months in the Netherlands: an open-label, parallel, randomised controlled trial.

Barug D, Pronk I, van Houten MA, Versteegh FGA, Knol MJ, van de Kassteele J, Berbers GAM, Sanders EAM, Rots NY.

Lancet Infect Dis. 2019 Apr;19(4):392-401. doi: 10.1016/S1473-3099(18)30717-5. Epub 2019 Mar 27.

PMID:
30938299
4.

Prediction and Validation of Immunogenic Domains of Pneumococcal Proteins Recognized by Human CD4+ T Cells.

van de Garde MDB, van Westen E, Poelen MCM, Rots NY, van Els CACM.

Infect Immun. 2019 May 21;87(6). pii: e00098-19. doi: 10.1128/IAI.00098-19. Print 2019 Jun.

5.

Immunogenicity of Influenza Vaccines: Evidence for Differential Effect of Secondary Vaccination on Humoral and Cellular Immunity.

Rosendahl Huber SK, Hendriks M, Jacobi RHJ, van de Kassteele J, Mandersloot-Oskam JC, van Boxtel RAJ, Wensing AMJ, Rots NY, Luytjes W, van Beek J.

Front Immunol. 2019 Jan 29;9:3103. doi: 10.3389/fimmu.2018.03103. eCollection 2018.

6.

Serotype-Specific IgG Antibody Waning after Pneumococcal Conjugate Primary Series Vaccinations with either the 10-Valent or the 13-Valent Vaccine.

van Westen E, Knol MJ, Wijmenga-Monsuur AJ, Tcherniaeva I, Schouls LM, Sanders EAM, van Els CACM, Berbers GAM, Rots NY.

Vaccines (Basel). 2018 Dec 11;6(4). pii: E82. doi: 10.3390/vaccines6040082.

7.

Socioeconomic Status Is Associated With Antibody Levels Against Vaccine Preventable Diseases in the Netherlands.

Hoes J, Boef AGC, Knol MJ, de Melker HE, Mollema L, van der Klis FRM, Rots NY, van Baarle D.

Front Public Health. 2018 Jul 27;6:209. doi: 10.3389/fpubh.2018.00209. eCollection 2018.

8.

Increased carriage of non-vaccine serotypes with low invasive disease potential four years after switching to the 10-valent pneumococcal conjugate vaccine in The Netherlands.

Vissers M, Wijmenga-Monsuur AJ, Knol MJ, Badoux P, van Houten MA, van der Ende A, Sanders EAM, Rots NY.

PLoS One. 2018 Mar 30;13(3):e0194823. doi: 10.1371/journal.pone.0194823. eCollection 2018.

9.

Immunodominance in T cell responses elicited against different domains of detoxified pneumolysin PlyD1.

van Westen E, Poelen MCM, van den Dobbelsteen GPJM, Oloo EO, Ochs MM, Rots NY, van Els CACM.

PLoS One. 2018 Mar 6;13(3):e0193650. doi: 10.1371/journal.pone.0193650. eCollection 2018.

10.

Differences by sex in IgG levels following infant and childhood vaccinations: An individual participant data meta-analysis of vaccination studies.

Boef AGC, van der Klis FRM, Berbers GAM, Buisman AM, Sanders EAM, Kemmeren JM, van der Ende A, de Melker HE, Rots NY, Knol MJ.

Vaccine. 2018 Jan 8;36(3):400-407. doi: 10.1016/j.vaccine.2017.11.070. Epub 2017 Dec 6.

PMID:
29223483
11.

Influenza-like Illness Incidence Is Not Reduced by Influenza Vaccination in a Cohort of Older Adults, Despite Effectively Reducing Laboratory-Confirmed Influenza Virus Infections.

van Beek J, Veenhoven RH, Bruin JP, van Boxtel RAJ, de Lange MMA, Meijer A, Sanders EAM, Rots NY, Luytjes W.

J Infect Dis. 2017 Aug 15;216(4):415-424. doi: 10.1093/infdis/jix268.

PMID:
28931240
12.

Molecular surveillance on Streptococcus pneumoniae carriage in non-elderly adults; little evidence for pneumococcal circulation independent from the reservoir in children.

Wyllie AL, Rümke LW, Arp K, Bosch AATM, Bruin JP, Rots NY, Wijmenga-Monsuur AJ, Sanders EAM, Trzciński K.

Sci Rep. 2016 Oct 7;6:34888. doi: 10.1038/srep34888.

13.

Correction: Direct Comparison of Immunogenicity Induced by 10- or 13-Valent Pneumococcal Conjugate Vaccine around the 11-Month Booster in Dutch Infants.

Wijmenga-Monsuur AJ, van Westen E, Knol MJ, Jongerius RM, Zancolli M, Goldblatt D, van Gageldonk PG, Tcherniaeva I, Berbers GA, Rots NY.

PLoS One. 2016 May 11;11(5):e0155088. doi: 10.1371/journal.pone.0155088. eCollection 2016.

14.

Molecular surveillance of nasopharyngeal carriage of Streptococcus pneumoniae in children vaccinated with conjugated polysaccharide pneumococcal vaccines.

Wyllie AL, Wijmenga-Monsuur AJ, van Houten MA, Bosch AATM, Groot JA, van Engelsdorp Gastelaars J, Bruin JP, Bogaert D, Rots NY, Sanders EAM, Trzciński K.

Sci Rep. 2016 Apr 5;6:23809. doi: 10.1038/srep23809.

15.

Nasopharyngeal carriage of Streptococcus pneumoniae and other bacteria in the 7th year after implementation of the pneumococcal conjugate vaccine in the Netherlands.

Bosch AATM, van Houten MA, Bruin JP, Wijmenga-Monsuur AJ, Trzciński K, Bogaert D, Rots NY, Sanders EAM.

Vaccine. 2016 Jan 20;34(4):531-539. doi: 10.1016/j.vaccine.2015.11.060. Epub 2015 Dec 5.

16.

Direct Comparison of Immunogenicity Induced by 10- or 13-Valent Pneumococcal Conjugate Vaccine around the 11-Month Booster in Dutch Infants.

Wijmenga-Monsuur AJ, van Westen E, Knol MJ, Jongerius RM, Zancolli M, Goldblatt D, van Gageldonk PG, Tcherniaeva I, Berbers GA, Rots NY.

PLoS One. 2015 Dec 10;10(12):e0144739. doi: 10.1371/journal.pone.0144739. eCollection 2015. Erratum in: PLoS One. 2016;11(5):e0155088.

17.

Differential B-cell memory around the 11-month booster in children vaccinated with a 10- or 13-valent pneumococcal conjugate vaccine.

van Westen E, Wijmenga-Monsuur AJ, van Dijken HH, van Gaans-van den Brink JA, Kuipers B, Knol MJ, Berbers GA, Sanders EA, Rots NY, van Els CA.

Clin Infect Dis. 2015 Aug 1;61(3):342-9. doi: 10.1093/cid/civ274. Epub 2015 Apr 1.

18.

Carriage of Streptococcus pneumoniae in aged adults with influenza-like-illness.

Krone CL, Wyllie AL, van Beek J, Rots NY, Oja AE, Chu ML, Bruin JP, Bogaert D, Sanders EA, Trzciński K.

PLoS One. 2015 Mar 19;10(3):e0119875. doi: 10.1371/journal.pone.0119875. eCollection 2015.

19.

Comparing vaccines: a systematic review of the use of the non-inferiority margin in vaccine trials.

Donken R, de Melker HE, Rots NY, Berbers G, Knol MJ.

Vaccine. 2015 Mar 17;33(12):1426-32. doi: 10.1016/j.vaccine.2015.01.072. Epub 2015 Feb 7. Review.

PMID:
25659273
20.

Parents' attitude toward multiple vaccinations at a single visit with alternative delivery methods.

Kaaijk P, Kleijne DE, Knol MJ, Harmsen IA, Ophorst OJ, Rots NY.

Hum Vaccin Immunother. 2014;10(8):2483-9. doi: 10.4161/hv.29361.

21.

Safety and immunogenicity of a primary series of Sabin-IPV with and without aluminum hydroxide in infants.

Verdijk P, Rots NY, van Oijen MG, Weldon WC, Oberste MS, Okayasu H, Sutter RW, Bakker WA.

Vaccine. 2014 Sep 3;32(39):4938-44. doi: 10.1016/j.vaccine.2014.07.029. Epub 2014 Jul 18.

PMID:
25043278
22.

Seven-valent pneumococcal conjugate vaccine and nasopharyngeal microbiota in healthy children.

Biesbroek G, Wang X, Keijser BJ, Eijkemans RM, Trzciński K, Rots NY, Veenhoven RH, Sanders EA, Bogaert D.

Emerg Infect Dis. 2014 Feb;20(2):201-10. doi: 10.3201/eid2002.131220.

23.

Levels and functionality of antibodies after pneumococcal conjugate vaccine in schedules with different timing of the booster dose.

van Westen E, Rodenburg GD, van Gils EJ, Tcherniaeva I, Berbers GA, Cowell L, Goldblatt D, Rots NY, van den Dobbelsteen GP, Sanders EA.

Vaccine. 2013 Dec 2;31(49):5834-42. doi: 10.1016/j.vaccine.2013.09.073. Epub 2013 Oct 10.

24.

Safety and immunogenicity of inactivated poliovirus vaccine based on Sabin strains with and without aluminum hydroxide: a phase I trial in healthy adults.

Verdijk P, Rots NY, van Oijen MG, Oberste MS, Boog CJ, Okayasu H, Sutter RW, Bakker WA.

Vaccine. 2013 Nov 12;31(47):5531-6. doi: 10.1016/j.vaccine.2013.09.021. Epub 2013 Sep 21.

PMID:
24063976
25.

Intradermal fractional booster dose of inactivated poliomyelitis vaccine with a jet injector in healthy adults.

Soonawala D, Verdijk P, Wijmenga-Monsuur AJ, Boog CJ, Koedam P, Visser LG, Rots NY.

Vaccine. 2013 Aug 12;31(36):3688-94. doi: 10.1016/j.vaccine.2013.05.104. Epub 2013 Jun 13.

PMID:
23770332
26.

Vaccination against RSV: is maternal vaccination a good alternative to other approaches?

Kaaijk P, Luytjes W, Rots NY.

Hum Vaccin Immunother. 2013 Jun;9(6):1263-7. doi: 10.4161/hv.24096. Epub 2013 Feb 26.

27.

Is a single dose of meningococcal serogroup C conjugate vaccine sufficient for protection? experience from the Netherlands.

Kaaijk P, van der Ende A, Berbers G, van den Dobbelsteen GP, Rots NY.

BMC Infect Dis. 2012 Feb 8;12:35. doi: 10.1186/1471-2334-12-35.

28.

Clinical development of a novel inactivated poliomyelitis vaccine based on attenuated Sabin poliovirus strains.

Verdijk P, Rots NY, Bakker WA.

Expert Rev Vaccines. 2011 May;10(5):635-44. doi: 10.1586/erv.11.51. Review.

PMID:
21604984
29.

Phacilitate, Barcelona Vaccine Forum 2010: focus on correlates of protection against influenza.

Soethout EC, Bakker WA, van Dam RH, Rots NY, Boog CJ.

Hum Vaccin. 2010 Dec;6(12):964-5. Epub 2010 Dec 1. No abstract available.

PMID:
21150272
30.

Hepatitis B vaccination strategies tailored to different endemicity levels: some considerations.

Rots NY, Wijmenga-Monsuur AJ, Luytjes W, Kaaijk P, de Graaf TW, van der Zeijst BA, Boog CJ.

Vaccine. 2010 Jan 22;28(4):893-900. doi: 10.1016/j.vaccine.2009.10.125. Epub 2009 Nov 20. Review.

PMID:
19932217
32.
33.

Stress hormones, genotype, and brain organization. Implications for aggression.

De Kloet ER, Korte SM, Rots NY, Kruk MR.

Ann N Y Acad Sci. 1996 Sep 20;794:179-91. Review. No abstract available.

PMID:
8853602
34.

Neonatal maternally deprived rats have as adults elevated basal pituitary-adrenal activity and enhanced susceptibility to apomorphine.

Rots NY, de Jong J, Workel JO, Levine S, Cools AR, De Kloet ER.

J Neuroendocrinol. 1996 Jul;8(7):501-6.

PMID:
8843018
35.

Brain-corticosteroid hormone dialogue: slow and persistent.

de Kloet ER, Rots NY, Cools AR.

Cell Mol Neurobiol. 1996 Jun;16(3):345-56. Review.

PMID:
8818401
36.

Divergent prolactin and pituitary-adrenal activity in rats selectively bred for different dopamine responsiveness.

Rots NY, Cools AR, Oitzl MS, de Jong J, Sutanto W, de Kloet ER.

Endocrinology. 1996 May;137(5):1678-86.

PMID:
8612501
37.

Development of divergence in dopamine responsiveness in genetically selected rat lines is preceded by changes in pituitary-adrenal activity.

Rots NY, Workel J, Oitzl MS, Bérod A, Rostène W, Cools AR, De Kloet ER.

Brain Res Dev Brain Res. 1996 Apr 30;92(2):164-71.

PMID:
8738123
38.
39.

Corticosteroid feedback resistance in rats genetically selected for increased dopamine responsiveness.

Rots NY, Cools AR, de Jong J, De Kloet ER.

J Neuroendocrinol. 1995 Feb;7(2):153-61. Erratum in: J Neuroendocrinol 1995 Apr;7(4):280.

PMID:
7767328
40.

Brain mineralocorticoid receptor function.

de Kloet ER, Rots NY, van den Berg DT, Oitzl MS.

Ann N Y Acad Sci. 1994 Nov 30;746:8-20; discussion 20-1, 64-7. Review. No abstract available.

PMID:
7825924
41.

Brain mineralocorticoid receptor diversity: functional implications.

de Kloet ER, Sutanto W, van den Berg DT, Carey MP, van Haarst AD, Hornsby CD, Meijer OC, Rots NY, Oitzl MS.

J Steroid Biochem Mol Biol. 1993 Dec;47(1-6):183-90. Review.

PMID:
8274434
43.

Corticosteroid receptor plasticity in the central nervous system of various rat models.

Sutanto W, Oitzl MS, Rots NY, Schöbitz B, Van den Berg DT, Van Dijken HH, Mos J, Cools AR, Tilders FJ, Koolhaas JM, et al.

Endocr Regul. 1992 Sep;26(3):111-8.

PMID:
1339189
44.

The effect of aging on stress responsiveness and central corticosteroid receptors in the brown Norway rat.

van Eekelen JA, Rots NY, Sutanto W, de Kloet ER.

Neurobiol Aging. 1992 Jan-Feb;13(1):159-70.

PMID:
1311803
45.

Enhanced Neurohypophyseal Vasopressin Release is Associated with Increased Opioid Inhibition of Oxytocin Release.

Heijning BJ, Herik IK, Rots NY, Greidanus TB.

J Neuroendocrinol. 1991 Feb 1;3(1):57-64. doi: 10.1111/j.1365-2826.1991.tb00239.x.

PMID:
19215447
46.

Brain corticosteroid receptor gene expression and neuroendocrine dynamics during aging.

van Eekelen JA, Rots NY, Sutanto W, Oitzl MS, de Kloet ER.

J Steroid Biochem Mol Biol. 1991;40(4-6):679-83.

PMID:
1659889

Supplemental Content

Support Center